|
End-of-day quote
Taipei Exchange
21/10/2026
|
5-day change | 1st Jan Change | ||
| 88.50 TWD | +2.67% |
|
+4.49% | -70.89% |
| Market Cap | 5.91B 182M 162M 150M 136M 256M 17.2B 259M 1.8B 707M 9.04B 684M 669M 28.8B | P/E 2024 |
524x | P/E 2025 | -255x |
|---|---|---|---|---|---|
| Enterprise Value | 3.62B 112M 99.4M 92.03M 83.29M 157M 10.53B 159M 1.1B 433M 5.53B 418M 410M 17.63B | EV / Sales 2024 |
1,207x | EV / Sales 2025 | 6,544x |
| Free-Float |
58.96% | Yield 2024 |
0.18% | Yield 2025 | 0.03% |
| 1 day | +2.67% | ||
| 1 week | +4.49% | ||
| Current month | -6.94% | ||
| 1 month | -11.06% | ||
| 3 months | -19.91% | ||
| 6 months | -47.32% | ||
| Current year | -70.89% |
| 1 week | 83.1 |  | 93 |
| 1 month | 81.1 | | 100 |
| Current year | 81.1 | | 313 |
| 1 year | 81.1 | | 317 |
| 3 years | 81.1 | | 465 |
| 5 years | 42.8 | | 465 |
| 10 years | 42.8 | | 465 |
| Manager | Title | Age | Since |
|---|---|---|---|
Yung Shun Wen
CEO | Chief Executive Officer | - | 23/09/2016 |
Vivian Kang
DFI | Director of Finance/CFO | - | 16/10/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
Charles Lin
CHM | Chairman | - | 23/09/2016 |
Yung Shun Wen
BRD | Director/Board Member | - | 23/09/2016 |
Cheng Yu Fang
BRD | Director/Board Member | - | 07/08/2018 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.67% | +4.49% | -70.00% | -56.40% | 176M | |
| -1.01% | +5.13% | +58.93% | +117.36% | 1,144B | |
| -0.61% | +1.52% | +34.34% | +68.48% | 625B | |
| -1.48% | +0.47% | +23.08% | +94.76% | 511B | |
| +0.54% | +5.69% | +39.60% | +64.02% | 377B | |
| +1.07% | +1.70% | +71.06% | +45.98% | 366B | |
| +0.30% | +3.44% | +21.35% | +49.62% | 291B | |
| -0.03% | +2.55% | +1.12% | +20.94% | 262B | |
| -0.14% | +2.87% | +45.56% | +57.22% | 237B | |
| -1.88% | +0.02% | +23.77% | +97.39% | 194B | |
| Average | +0.24% | +4.07% | +24.88% | +55.94% | 400.81B | |
| Weighted average by Cap. | +0.33% | +4.17% | +40.81% | +79.56% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 5.82M 179K 160K 148K 134K 252K 16.92M 255K 1.77M 696K 8.89M 673K 659K 28.34M | 2.75M 84.86K 75.62K 70.01K 63.36K 119K 8.01M 121K 839K 329K 4.21M 318K 312K 13.41M |
| Net income | 18.17M 560K 499K 462K 418K 788K 52.85M 797K 5.54M 2.17M 27.78M 2.1M 2.06M 88.53M | -79.68M -2.46M -2.19M -2.03M -1.83M -3.45M -232M -3.5M -24.3M -9.53M -122M -9.21M -9.02M -388M |
| Net Debt | -2.43B -74.92M -66.76M -61.81M -55.93M -105M -7.07B -107M -741M -291M -3.72B -281M -275M -11.84B | -2.29B -70.67M -62.98M -58.31M -52.77M -99.41M -6.67B -101M -699M -274M -3.51B -265M -260M -11.17B |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 21/10/26 | NT$88.50 | +2.67% | 84,843 |
| 20/10/26 | NT$86.20 | -0.23% | 26,056 |
| 19/10/26 | NT$86.40 | +0.82% | 26,987 |
| 16/10/26 | NT$85.70 | +3.13% | 49,393 |
| 15/10/26 | NT$83.10 | -1.89% | 71,781 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 6785 Stock
Select your edition
All financial news and data tailored to specific country editions
